Doxycycline to Treat Mansonella Perstans Infection in Patients With and Without Lymphatic Filariasis

NCT00340691 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1500

Enrollment

NIH

Sponsor class

Conditions

Mansonella Perstans Infection
Mp Microfilaremia

Interventions

DRUG: Doxycycline

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)